TetraLogic Pharmaceuticals Corporation (NasdaqGM:TLOG) is seeking acquisitions. TetraLogic announces pricing of $25 million of public offering. TetraLogic Pharmaceuticals said in Sec Filling, “TetraLogic anticipates using the net proceeds from the offering for general corporate purposes, including working capital, continued development of its product candidate pipeline, acquisitions and other business opportunities.”